Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Can stereotactic radiofrequency ablation replace liver resection?

Can stereotactic radiofrequency ablation replace liver resection? Percutaneous radiofrequency ablation (RFA) is a minimal invasive potentially curative local ablative tumour treatment with very low morbidity and mortality rates as compared to surgery. The question arises whether RFA can replace liver resection. Recent studies have shown that patient long-term survival data after RFA approach the resection data despite inclusion of patients with a poorer prognosis due to comorbidities or disadvantageous tumour distribution. However, since most of the data still favour resection conventional RFA is currently only considered the primary local tumour treatment in combination with surgery or in patients with unresectable colorectal liver metastases (CRLM). Recent improvements in ablation technology and the application of stereotaxy for probe placement have led to local control rates approaching the rates of R0 resections. If stereotactic radiofrequency ablation (SRFA) achieves similar survival rates as compared to resection it may be the method of first choice in patients with potentially resectable colorectal liver metastases. Randomised controlled studies comparing resection and SRFA could finally answer the title question. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png memo - Magazine of European Medical Oncology Springer Journals

Can stereotactic radiofrequency ablation replace liver resection?

Download PDF
4 pages

Loading next page...
 
/lp/springer-journals/can-stereotactic-radiofrequency-ablation-replace-liver-resection-SA0DKrylOE
Publisher
Springer Journals
Copyright
Copyright © 2011 by Springer-Verlag
Subject
Medicine & Public Health; Medicine/Public Health, general; Oncology
ISSN
1865-5041
eISSN
1865-5076
DOI
10.1007/s12254-011-0266-3
Publisher site
See Article on Publisher Site

Abstract

Percutaneous radiofrequency ablation (RFA) is a minimal invasive potentially curative local ablative tumour treatment with very low morbidity and mortality rates as compared to surgery. The question arises whether RFA can replace liver resection. Recent studies have shown that patient long-term survival data after RFA approach the resection data despite inclusion of patients with a poorer prognosis due to comorbidities or disadvantageous tumour distribution. However, since most of the data still favour resection conventional RFA is currently only considered the primary local tumour treatment in combination with surgery or in patients with unresectable colorectal liver metastases (CRLM). Recent improvements in ablation technology and the application of stereotaxy for probe placement have led to local control rates approaching the rates of R0 resections. If stereotactic radiofrequency ablation (SRFA) achieves similar survival rates as compared to resection it may be the method of first choice in patients with potentially resectable colorectal liver metastases. Randomised controlled studies comparing resection and SRFA could finally answer the title question.

Journal

memo - Magazine of European Medical Oncology – Springer Journals

Published: Jun 30, 2011

References

  • Factors influencing the natural history of colorectal liver metastases
    Stangl, R; Altendorf-Hofmann, A; Charnley, RM
  • Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy
    Knudsen, AR; Kannerup, AS; Mortensen, FV
  • Surgical therapy for colorectal metastases to the liver
    Pawlik, TM; Choti, MA
  • Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases
    Pawlik, TM; Scoggins, CR; Zorzi, D
  • Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy
    Kornprat, P; Jarnagin, WR; Gonen, M
  • Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases
    Abdalla, EK; Vauthey, JN; Ellis, LM
  • Trends in longterm survival following liver resection for hepatic colorectal metastases
    Choti, MA; Sitzmann, JV; Tiburi, MF
  • Morbidity and mortality after liver resection: results of the patient safety in surgery study
    Virani, S; Michaelson, JS; Hutter, M
  • Survival after hepatic resection of colorectal cancer metastases – a national experience
    Robertson, DJ; Stukel, TA; Gottlieb, DJ
  • Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients
    Solbiati, L; Livraghi, T; Goldberg, SN
  • Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year
    De Baere, T; Elias, D; Dromain, C
  • Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study
    Livraghi, T; Solbiati, L; Meloni, MF
  • Adverse events during radiofrequency treatment of 582 hepatic tumors
    De Baere, T; Risse, O; Kuoch, V
  • Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation
    Goldberg, SN; Gazelle, GS; Compton, CC
  • American society of clinical oncology 2009. Clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer
    Wong, SL; Mangu, PB; Choti, MA
  • Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection
    Kokudo, N; Miki, Y; Sugai, S
  • Local surgical, ablative, and radiation treatment of metastases
    Timmerman, RD; Bizekis, CS; Pass, HI; Fong, Y
  • Radiofrequency ablation of hepatic metastases from colorectal cancer: are newer generation probes better?
    Ahmad, A; Chen, SL; Kavanagh, MA
  • Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first- and second-line management
    Machi, J; Oishi, AJ; Sumida, K
  • Long-term survival after radiofrequency ablation of complex unresectable liver tumors
    Amersi, FF; McElrath-Garza, A; Ahmad, A
  • Stereotaxy: breaking the limits of current radiofrequency ablation techniques
    Bale, R; Widmann, G; Stoffner, DI
  • Radio-frequency ablation of colorectal liver metastases in 167 patients
    Gillams, AR; Lees, WR
  • Radiofrequency ablation of colorectal liver metastases: long-term survival
    Sorensen, SM; Mortensen, FV; Nielsen, DT
  • Radiofrequency ablation combined with chemotherapy for unresectable colorectal liver metastases: interim results of a randomised phase II study of the EORTC-NCRI CCSG-ALM Intergroup 40004 (CLOCC)
    Ruers, T; van Coevorden, F; Pierie, J
  • Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery
    Park, IJ; Kim, HC; Yu, CS
  • Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent?
    Reuter, NP; Woodall, CE; Scoggins, CR
  • Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases
    Elias, D; Baton, O; Sideris, L
  • Resection versus laparoscopic radiofrequency thermal ablation of solitary colorectal liver metastasis
    Berber, E; Tsinberg, M; Tellioglu, G
  • Radiofrequency ablation as first-line treatment in patients with early colorectal liver metastases amenable to surgery
    Otto, G; Düber, C; Hoppe-Lotichius, M; König, J; Heise, M; Pitton, MB